Neuroendocrine and Inflammatory Responses to Losartan and Continuous Positive Airway Pressure in Patients with Hypertension and Obstructive Sleep Apnea. A Randomized Controlled Trial

Thunström, Erik; Manhem, Karin; Yucel-Lindberg, Tülay; Rosengren, Annika; Lindberg, Caroline; Peker, Yüksel
November 2016
Annals of the American Thoracic Society;Nov2016, Vol. 13 Issue 11, p2002
Academic Journal
journal article
Rationale: Blood pressure reduction in response to antihypertensive agents is less for patients with obstructive sleep apnea (OSA). Increased sympathetic and inflammatory activity, as well as alterations in the renin-angiotensin-aldosterone system, may play a role in this context.Objectives: To address the cardiovascular mechanisms involved in response to an angiotensin II receptor antagonist, losartan, and continuous positive airway pressure (CPAP) as add-on treatment for hypertension and OSA.Methods: Newly diagnosed hypertensive patients with or without OSA (allocated in a 2:1 ratio for OSA vs. no OSA) were treated with losartan 50 mg daily during a 6-week two-center, open-label, prospective, case-control, parallel-design study. In the second 6-week, sex-stratified, open-label, randomized, parallel-design study, all subjects with OSA continued to receive losartan and were randomly assigned to either CPAP as add-on therapy or to no CPAP (1:1 ratio for CPAP vs. no CPAP). Study subjects without OSA were followed in parallel while they continued to take losartan. Blood samples were collected at baseline, after 6 weeks, and after 12 weeks for analysis of renin, aldosterone, noradrenaline, adrenaline, and inflammatory markers.Measurements and Main Results: Fifty-four patients with OSA and 35 without OSA were included in the first 6-week study. Losartan significantly increased renin levels and reduced aldosterone levels in the group without OSA. There was no significant decrease in aldosterone levels among patients with OSA. Add-on CPAP treatment tended to lower aldosterone levels, but reductions were more pronounced in measures of sympathetic activity. No significant changes in inflammatory markers were observed following treatment with losartan and CPAP.Conclusions: Hypertensive patients with OSA responded to losartan treatment with smaller reductions in aldosterone compared with hypertensive patients without OSA. Sympathetic system activity seemed to respond primarily to add-on CPAP treatment in patients with newly discovered hypertension and OSA. Clinical trial registered with www.clinicaltrials.gov (NCT00701428).


Related Articles

  • Effect of CPAP on Blood Pressure in Patients With Obstructive Sleep Apnea and Resistant Hypertension. Martínez-García, Miguel-Angel; Capote, Francisco; Campos-Rodríguez, Francisco; Lloberes, Patricia; Díaz de Atauri, María Josefa; Somoza, María; Masa, Juan F.; González, Mónica; Sacristán, Lirios; Barbé, Ferrán; Durán-Cantolla, Joaquín; Aizpuru, Felipe; Mañas, Eva; Barreiro, Bienvenido; Mosteiro, Mar; Cebrián, Juan J.; de la Peña, Mónica; García-Río, Francisco; Maimó, Andrés; Zapater, // JAMA: Journal of the American Medical Association;12/11/2013, Vol. 310 Issue 22, p2407 

    IMPORTANCE More than 70%of patients with resistant hypertension have obstructive sleep apnea (OSA). However, there is little evidence about the effect of continuous positive airway pressure (CPAP) treatment on blood pressure in patients with resistant hypertension. OBJECTIVE To assess the effect...

  • Physician Decision Making and Clinical Outcomes With Laboratory Polysomnography or Limited-Channel Sleep Studies for Obstructive Sleep Apnea: A Randomized Trial. Ching Li Chai-Coetzer; Antic, Nick A.; McEvoy, R. Doug; Hamilton, Garun S.; McArdle, Nigel; Wong, Keith; Yee, Brendon J.; Aeneas Yeo; Ratnavadivel, Rajeev; Naughton, Matthew T.; Roebuck, Teanau; Woodman, Richard; Chai-Coetzer, Ching Li; Yeo, Aeneas // Annals of Internal Medicine;3/7/2017, Vol. 166 Issue 5, p332 

    Background: The clinical utility of limited-channel sleep studies (which are increasingly conducted at home) versus laboratory polysomnography (PSG) for diagnosing obstructive sleep apnea (OSA) is unclear.Objective: To compare patient outcomes after PSG versus...

  • Impact of Mandibular Advancement Therapy on Endothelial Function in Severe Obstructive Sleep Apnea. Gagnadoux, Frédéric; Pépin, Jean-Louis; Vielle, Bruno; Bironneau, Vanessa; Chouet-Girard, Frédérique; Launois, Sandrine; Meslier, Nicole; Meurice, Jean-Claude; Xuan-Lan Nguyen; Paris, Audrey; Priou, Pascaline; Tamisier, Renaud; Trzepizur, Wojciech; Goupil, François; Fleury, Bernard; Nguyen, Xuan-Lan // American Journal of Respiratory & Critical Care Medicine;5/1/2017, Vol. 195 Issue 9, p1244 

    Rationale: Endothelial dysfunction, a major predictor of late cardiovascular events, is linked to the severity of obstructive sleep apnea (OSA).Objectives: To determine whether treatment with mandibular advancement device, the main alternative to continuous positive...

  • Update in Sleep-disordered Breathing 2016. Ayas, Najib T.; Drager, Luciano F.; Morrell, Mary J.; Polotsky, Vsevolod Y. // American Journal of Respiratory & Critical Care Medicine;6/15/2017, Vol. 195 Issue 12, p1561 

    The field of sleep disordered breathing has continued to evolve with many important articles published in the last year. In this review, we have summarized some of the key articles relevant to sleep disordered breathing that have been published in the Journal and selected articles published...

  • Nerve monitoring-guided selective hypoglossal nerve stimulation in obstructive sleep apnea patients. Heiser, Clemens; Hofauer, Benedikt; Lozier, Luke; Woodson, B. Tucker; Stark, Thomas // Laryngoscope;Dec2016, Vol. 126 Issue 12, p2852 

    Objective/hypothesis: Selective stimulation of the upper airway is a new therapy for obstructive sleep apnea. The aim of the study was to determine if a selective nerve integrity monitoring (NIM) system could aid in precise placement of the cuff electrode in selective upper-airway...

  • 2016 - In CVD with moderate-to-severe obstructive sleep apnea, adding CPAP to usual care did not reduce major CV events. Arepally, Sandeep; Blanchard, Amy R. // ACP Journal Club;11/15/2016, Vol. 165 Issue 10, p1 

    Question In patients with cardiovascular disease (CVD) and moderate-to-severe obstructive sleep apnea (OSA), does adding continuous positive airway pressure (CPAP) to usual care reduce CV events? Methods Design Randomized controlled trial (RCT) with minimization (Sleep Apnea Cardiovascular...

  • In patients with obstructive sleep apnea and resistant hypertension, CPAP reduced 24-hour blood pressure. Kaw, Roop // ACP Journal Club;4/15/2014, Vol. 160 Issue 8, p1 

    The article presents a study which evaluates the effectiveness of continuous positive airway pressure (CPAP) on blood pressure (BP) in patients with obstructive sleep apnea (OSA) and resistant hypertension. The study conducted randomized controlled trial for 12 weeks. The study concluded that...

  • Cardiovascular Outcomes in Action to Control Cardiovascular Risk in Diabetes: Impact of Blood Pressure Level and Presence of Kidney Disease. Papademetriou, Vasilios; Zaheer, Misbah; Doumas, Michael; Lovato, Laura; applegate, William B.; Tsioufis, Costas; Mottle, amy; Punthakee, Zubin; Cushman, William C. // American Journal of Nephrology;Jun2016, Vol. 43 Issue 4, p271 

    Background: Persons with chronic kidney disease (CKD) represent a population prone to cardiovascular disease (CVD) but vulnerable to adverse medication effects. We assessed the impact of intensive antihypertensive therapy on the cerebrovascular and other CVD outcomes in high-risk...

  • Effect of continuous positive airway pressure on blood pressure in hypertensive patients with coronary artery bypass grafting and obstructive sleep apnea. Yumei Dong; Yingnan Dai; Guoqian Wei; Li Cha; Xueqi Li // International Journal of Clinical & Experimental Medicine;2014, Vol. 7 Issue 11, p4308 

    Background: Previous studies have documented that obstructive sleep apnea (OSA) increases the incidence of hypertension, respiratory failure and unexpected post-operative deaths during night in coronary artery bypass grafting (CABG) patients. We hypothesized that continuous positive airway...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics